Skip to content
MMetabolicMomsTHE MAGAZINE FOR MOTHERS ON GLP-1
Menu
Grade C

NativeMed review

Monthly compounded semaglutide renews at $179 and tirzepatide at $259; lower rates require three-month prepayment. NativeMed now names VialsRx as a pharmacy partner, but cancellation-fee wording conflicts across its pages. FDA warning letter 728287, issued June 2026, cited misleading compounded-drug marketing. The letter concerns marketing claims rather than a patient-specific safety finding.

$159to start

then $179/mo ongoing

Flat price · every dose
Consult Medication Shipping
See plans at NativeMed
  • Six-factor Editors' Rating
  • Source-based review
Compare alternatives ↓
By Margaux Ellery, Editor-in-Chiefa mother on the MetabolicMoms desk, not a treating clinician

This review draws on the provider’s public pricing, terms and disclosures. No one on this desk is your clinician.

NativeMed at a glance

Semaglutide
$179/month after $159 first month; $149/month on three-month prepay
Tirzepatide
$259/month after $199 first month; $183/month on three-month prepay
Coverage
Complete state list not established; confirm consultation and pharmacy eligibility
Brand-name
Compounded only

How we scored NativeMed

Each score comes out of NativeMed's published pricing, disclosures and oversight, and the six combine into the 58/100 Editors' Rating on our weighted six-factor framework. A commission never changes a provider's score.

Family-budget value68/100 · Weak

Cost is unpredictable, premium, or hides behind a plan commitment.

Clinical oversight & labs50/100 · Weak

Oversight and lab support fall short of the best we track — the review below says exactly where.

Pricing transparency55/100 · Weak

The headline rate obscures a plan requirement or a hidden step-up.

Fits around motherhood60/100 · Weak

Little here is shaped around a mother's week or her life stage.

Ongoing support & titration55/100 · Weak

Support is thin once the prescription ships.

Flexibility to pause or cancel58/100 · Weak

Leaving costs you — notice windows, minimum terms or fees you don't get back.

How we verified this review

Primary source
The company's own site

Monthly prices are $179 semaglutide/$259 tirzepatide after $159/$199 first months; prepaid three-month plans total $447/$549. Current pages name VialsRx and publish maternal safety cautions. Refund-fee and appointment-charge wording needs clarification. FDA’s June 2026 marketing letter remains disclosed without a current-status inference.

Before you sign up

We opened NativeMed's signup and stopped at the first screen that asked for personal details, so we can't tell you what comes after it. Here's what's worth knowing before you start.

These signup observations are from . The flow and offers may have changed; use the current pricing and terms in this review.

Worth knowing

  • Signup and care run through Bask Health, a third-party telehealth platform, rather than the brand's own system
  • The homepage shows "From $149/mo", which is the 3-month plan rate; the month-to-month price appears once you start the intake
  • Intake runs on a separate portal rather than NativeMed's main site

Pricing

MedicationPricePlan
Compounded semaglutide$159 → $179Monthly plan, every doseCurrent product page: $159 first month, then $179 per month. No four-week invoice cycle inferred.
Compounded tirzepatide$199 → $259Monthly plan, every doseCurrent product page: $199 first month, then $259 per month. Same-price-any-dose advertising.
Compounded semaglutide$149Three-month prepaid plan$447 paid up front for three months, advertised $149 per month.
Compounded tirzepatide$183Three-month prepaid plan$549 paid up front for three months, advertised $183 per month.

Swipe the table to see plan details →

GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from NativeMed's public disclosures at last review and change often; confirm the current number on NativeMed's own site.

What we like

  • Publishes monthly renewal and prepaid prices for both compounded molecules
  • Advertises the same treatment price at every dose
  • Current Pharmacy Services page names VialsRx with address and contact details
  • Current medication-safety page discusses pregnancy, breastfeeding and tirzepatide contraception concerns

The caveats

  • FDA warning letter 728287, issued June 8, 2026, cited misleading compounded-drug marketing; it is not a patient-specific safety finding
  • The $149/$183 headlines require three-month prepayment of $447/$549
  • Homepage no-cancellation-fee wording conflicts with a refund policy allowing an administrative fee for eligible early cancellation
  • Terms describe possible $25 appointment charges and additional maintenance-call fees; confirm current applicability
  • No complete state list or assigned clinician was established from the public pages inspected

NativeMed: clear prices, with an FDA disclosure to weigh

NativeMed publishes monthly compounded semaglutide at $179 and tirzepatide at $259, with lower introductory and prepaid prices. Its current site names VialsRx as a pharmacy partner. NativeMed also received FDA warning letter 728287 in June 2026 for misleading compounded-drug marketing. Compare the financial terms and clinical accountability alongside that disclosure before choosing it.

Compare the renewal bill with the prepaid offer

The semaglutide page lists $159 for the first month, followed by $179 per month. Its three-month alternative is $447 paid up front, advertised as $149 per month. Tirzepatide is $199 for the first month, then $259 per month, or $549 paid up front for the three-month plan, advertised as $183 per month. Those are different purchase commitments. The homepage’s smaller figures do not describe the ordinary monthly renewal.

Both product pages say the price is the same at any dose and that there are no hidden fees. That is useful for a household budget because a prescribed increase would not itself raise the advertised medication price. It is still a seller’s offer, rather than a promise that every service is included forever. Confirm your selected plan, total charge, next billing date and what happens if your clinician pauses treatment. No four-week invoice interval was established from the monthly wording.

The program also advertises no membership fees and free shipping if prescribed. Its January 2024 Terms nevertheless describe possible appointment and maintenance-call charges. A $25 charge may apply if you decline to proceed during the consultation; a $25 late-cancellation or no-show fee is described for appointments canceled within two hours. Maintenance calls carry an additional, unspecified charge. Ask which of these older provisions applies to your current offer, rather than assuming no hidden fees means no possible extras.

Cancellation and refunds need a written answer

The homepage says there are no long-term contracts or cancellation fees and that you are responsible only for medication already shipped. The separately linked refund policy is narrower: payments are generally nonrefundable, with a refund request permitted within twenty-four hours of purchase before medication has shipped, subject to an administrative cancellation fee. The policy does not state that fee’s amount. Those statements should be reconciled before you pay.

The refund page directs requests to the email contact on its refund page, with Cancellation Request in the subject line. It says eligible card refunds are credited within ten business days after eligibility is confirmed. The general program Terms permit termination on prior written notice, but the inspected pages do not give a precise cutoff for stopping a future monthly renewal. Ask for that date and confirmation that another prescription will not be sent. Stopping future care is different from recovering an unused prepaid balance.

The named pharmacy is an improvement in transparency

NativeMed’s Pharmacy Services page, dated September 17, 2026, names VialsRx in Tomball, Texas, with an address and phone number. That updates the older picture of a seller naming only U.S.-based pharmacies. The page says the actual dispensing pharmacy will be identified on the prescription label or accompanying paperwork, and that availability depends on the prescription, location and other requirements. A named partner does not establish that every patient receives medication from that pharmacy.

The Terms distinguish NativeMed’s administrative platform from independent clinical practices and providers, and reference NativeMed Healthcare LLC in the consultation arrangement. They do not identify the clinician assigned to your order. Ask for that person’s name and contact route. The consent describes video interaction, but a general consent document does not establish the exact visit required for every patient. The site’s approval-in-minutes advertising should not become an expectation that assessment cannot take longer.

The homepage advertises overnight delivery, while its FAQ says orders typically ship within one to three business days after approval and pharmacy processing. That is a dispatch estimate, not a guarantee that medicine reaches you the day after applying. Keep the approval, fulfillment and delivery dates separate when planning around travel or an existing prescription.

What the FDA letter actually concerns

FDA’s June 8, 2026 letter identifies NativeMed LLC doing business as NativeMed and its own storefront. It cites a pictured tirzepatide label bearing NativeMed’s logo, which the agency said suggested the company compounded the medicine when it did not. It also cites semaglutide marketing implying evaluation or approval comparable to approved brands. These are NativeMed’s own marketing findings, not a letter assigned through a similar company name.

The current site expressly says compounded products are not FDA-approved or approved substitutes for branded medicines. That disclosure does not prove FDA has accepted corrective action. No published closeout was found in the FDA record checked for this review; we do not infer the current enforcement status from a webpage remaining online. The letter also does not establish that an individual patient’s vial failed testing or that the business was ordered closed.

Questions that matter around motherhood

NativeMed now publishes pregnancy and breastfeeding cautions on its medication-safety page. It tells patients to disclose pregnancy plans and nursing, says semaglutide and tirzepatide should not be used during pregnancy, and discusses tirzepatide’s potential effect on oral contraception. That is useful disclosure; it does not demonstrate specialist postpartum care or settle your individual eligibility.

No complete state list was established from the pages read. Confirm availability where you will physically attend the telehealth visit, especially if you travel between states. NativeMed’s visible prices make an initial budget comparison possible, but the next step is resolving cancellation fees, your assigned clinician and pharmacy, and the plan’s exact renewal. Our guide to GLP-1 costs as doses change can help organize those questions. This review uses public information, without enrollment or treatment experience.

The bottom line for mothers

Best for: Mothers comparing visible monthly prices after resolving refund terms, pharmacy assignment and the FDA marketing disclosure.

Alternatives to NativeMed

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    The one program on our list whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.

    Visit CoreAge Rx
  • Bodybuilding Health+ does the disclosure part better than most of this market and the branding part more loosely. It names four compounding pharmacies outright with phone numbers, and it names two lead physicians with their NPI numbers — both of whom check out as active MDs in the federal registry. Pricing is flat at every dose and public before any intake: $179 a month for compounded semaglutide and $209 for tirzepatide, dropping to about $142 for a year of semaglutide or $175 for six months of tirzepatide paid up front. The looser part is the name. The operator is Dynamo Group LLC of Boca Raton, not Bodybuilding Health+'s website, and the 'trusted by millions since 1999' line on the page is the licensor's heritage rather than the clinic's.

    Visit Bodybuilding Health+
  • Compounded semaglutide at $165/mo and tirzepatide at $214/mo month to month, dropping to $97 and $177 on a 12-month plan — and the one program on our list that names pregnancy and breastfeeding in its own exclusion list rather than staying silent on it.

    Visit HealthRX

Providers like NativeMed

Keep comparing NativeMed

NativeMed, answered

What does NativeMed cost after the first month?
Current monthly product pages show semaglutide $159 first, then $179 per month; tirzepatide $199 first, then $259. Three-month prepaid options total $447/$549, advertised as $149/$183 per month.
Does NativeMed identify a pharmacy?
Yes. Its September 17, 2026 Pharmacy Services page lists VialsRx in Tomball, Texas. Actual dispensing depends on the prescription and location; confirm the pharmacy on your prescription paperwork.
Is NativeMed cancellation free?
The homepage says no cancellation fees, but the refund policy permits an administrative fee for a refund requested within twenty-four hours of purchase before shipment. Ask for the applicable fee and future-renewal cutoff before paying.
What is NativeMed’s FDA warning letter?
FDA letter 728287, issued June 8, 2026, cited misleading compounded-drug marketing on its own storefront. It does not establish a recall or an individual vial failure. The published letter does not establish the present enforcement status.
Does NativeMed discuss pregnancy or breastfeeding?
Its current medication-safety page asks patients to disclose pregnancy plans and nursing, says semaglutide and tirzepatide should not be used during pregnancy, and discusses tirzepatide oral-contraception concerns. This does not establish individual eligibility or specialist postpartum care.

Pricing, states and verification reflect NativeMed's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers